About
REV Clinical
The Momentum
Behind Your Milestones
Discover REV Clinical
We are a US-based CRO devoted to accelerating the delivery of life-changing therapies through scientific rigor, strong relationships with clinical sites in key global hubs, adaptability, and cost-effectiveness. We strive to be the most trusted partner in clinical research by advancing trials with speed and integrity, combining deep expertise, transparent collaboration, and scientific creativity to bring breakthrough therapeutic solutions to patients who need them.
Our
Promise
A New Name for a New Era in Clinical Research
For more than 15 years, we’ve guided sponsors through the complexities of early-phase trials as CBCC Global Research. As our vision and global reach expanded, we needed a name that reflects who we’ve become: a contract research organization (CRO) driven by momentum and progress. Our new name, REV Clinical, embodies our mission to advance promising therapies with speed, precision, and purpose. And when timelines tighten or challenges arise, REV responds with expertise, scientific creativity, and the strength of our Global Velocity Network™, keeping every milestone within reach.
For REV, rapid study initiation, successful onboarding, and studies with dramatically fewer change orders are rooted in our rigor in the project bidding stage. In some cases, even before a contract is signed, cross-functional medical and feasibility teams build and pressure-test the plan to ensure assumptions are accurate, timelines are met, and change orders become the exception, not the rule.
Executing with Reliability
Everyone. Every study. Every time.
Delivering Excellence
In science. In operations. In outcomes.
Driving Velocity
Moving with urgency. Purpose. Precision.
A Journey Fueled
by Purpose and
People
2010
Partnership with
CBCC Oncology Center
2010
CBCC Global Research established
2012
CBCC acquired Vibgyor Scientific Research in Ahmedabad, India
2021
Received first product approval from the U.S. FDA
2023
Completed first end-to-end
IND project in the U.S.
2024
20+ completed/ongoing
multi-country trials
2025
Partnership with
Edgewater Capital
2026
Rebranded as
REV Clinical
Strategic Partnership
with the CBCC
Oncology Center
CBCC Oncology Center
Through a strategic alliance with the CBCC Oncology Center in Bakersfield, California, REV gains access to world-class clinicians, facilities, and equipment, as well as ~4,000 new oncology patients annually. The center provides end-to-end care, including screening, biospecimen collection/testing, imaging, infusions, injections, and surgeries, within a 150,000-square-foot complex staffed by over 360 specialists. This partnership accelerates enrollment in REV’s oncology trials conducted in the US, deepens insights, and elevates our clinical execution.
Let’s Move Your Study Forward
Interested in connecting with REV Clinical’s team of interdisciplinary experts to answer questions, take action on your RFP, and clearly define next steps?